Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000060

Chief Medical Officer acquired 6,349 shares (option exercise)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2025-05-12 Option exercise 10b5-1 +6,349 $1.08 $6,857 118,035 D
Derivatives
Rodman David Malcom Chief Medical Officer 2025-05-12 Option exercise · Stock Option 10b5-1 −6,349 101,577 D
Loading xslF345X05/wk-form4_1747184222.xml…